<DOC>
	<DOCNO>NCT00623779</DOCNO>
	<brief_summary>The purpose study assess safety tolerability AZD0837 patient atrial fibrillation unable unwilling take vitamin K antagonist therapy 3 month .</brief_summary>
	<brief_title>Atrial Fibrillation ( AF ) Patients Not Taking Vitamin-K Antagonist ( VKA )</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Either one follow risk factor sufficient inclusion ( high risk patient ) Previous cerebral ischaemic attack ( stroke transient ischaemic attack ( TIA ) , &gt; 30 day prior randomization ) Previous systemic embolism least one follow risk factor need inclusion : Age â‰¥75 year Symptomatic congestive heart failure Impaired leave ventricular systolic function Diabetes mellitus ; Hypertension require antihypertensive treatment In addition AF patient must appropriate unable unwilling take VKA therapy Presence clinically significant valvular heart disease ; ; Stroke TIA and/or systemic embolism within previous 30 day prior randomization Conditions associate increase risk major bleeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>